Back to Search
Start Over
Clinical features and outcomes of patients with muscle-specific kinase antibody-positive myasthenia gravis in Japan.
- Source :
-
Journal of Neuroimmunology . Dec2023, Vol. 385, pN.PAG-N.PAG. 1p. - Publication Year :
- 2023
-
Abstract
- This study included 51 patients with muscle-specific kinase antibody-positive myasthenia gravis (MuSK-MG) from a Japanese multicenter survey to examine clinical features and outcomes. Median onset age was 37 years and female predominance was observed. All patients developed generalized symptoms and almost all (50/51) patients had bulbar symptoms. About half of the patients met the criteria for refractory MG. The refractory group had a lower age of onset, higher severity scores, and higher maximum daily doses of oral prednisolone compared to the nonrefractory group. The outcomes for MuSK-MG patients in Japan are not favorable, indicating the need for more aggressive treatment. • MuSK-MG was more common in females. • In MuSK-MG, female patients developed the disease at younger age than male patients. • All MuSK-MG cases were generalized MG, with almost all experiencing bulbar palsy. • The outcomes of patients with MuSK-MG in Japan were unfavorable. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 01655728
- Volume :
- 385
- Database :
- Academic Search Index
- Journal :
- Journal of Neuroimmunology
- Publication Type :
- Academic Journal
- Accession number :
- 174159213
- Full Text :
- https://doi.org/10.1016/j.jneuroim.2023.578241